SCHOTT PHARMA AG & CO. KGAA financial statements, including revenue, expenses, profit, and loss

The total revenue of 1SXP for the last quarter is 253.59 M EUR, and it's 8.28% higher compared to the previous quarter. The net income of Q3 24 is 46.26 M EUR.